CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO
Is Modafinil the New "Smart Drug" of Choice?
Vice News, in its August 31, 2015, on-line Health section, reported that modafinil, a controlled stimulant prescribed for the treatment of narcolepsy, is becoming the drug of choice among “smart drug” users. According to the article, this trend results from the findings of a recently published Oxford University review on modafinil, which concluded that the drug improves cognition, contrary to previous studies (Users Say the 'Smart Drug' Modafinil Is the New Adderall — Only Better).
 
To support her claim, the author of the article cites a variety of sources including interviews with members of various internet “smart drug” communities and data from informal drug use surveys. Interviewees for example, who were asked to explain their preference of modafinil over other stimulants such as Ritalin® and Adderall®, said they preferred modafinil because they experienced little to no adverse side effects. The author also draws attention to the results of a recent drug use survey conducted in Britain that showed one in five university students in the UK had used modafinil.
 
The Oxford University researchers who published the modafinil review commented that they did not intend for their review to promote modafinil use. The review instead was intended to raise awareness about the ethical issues surrounding the use of “neuroenhancers” and the methods used to study them.
 
Cerilliant offers a wide selection of solution-based Certified Reference Materials (CRMs) for amphetamine and non-amphetamine based stimulants including parent drugs and metabolites as well as their stable-labeled internal standards. These certified reference solutions are suitable for many mass spectrometry-based applications including forensic analysis, clinical toxicology, workplace drug testing, pain management, and sports testing. Since amphetamine and non-amphetamine based stimulants are classified as controlled substances, we supply most of these reference standards as DEA-exempt solutions for added convenience.
 
Click on the links below to view our complete listing of amphetamine and amphetamine-type stimulant certified reference standards:
 


Return to Article List


© 2018 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
Sigma-Aldrich is a subsidiary of Merck KGaA, Darmstadt, Germany
Products | News/Events | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact
Follow Us: Cerilliant Linkedin LinkedIn